Approximately 3,456 cartons of Nitrofurantoin Oral Suspension USP (25mg/5mL) are being recalled because the medication may be subpotent and has failed content uniformity tests. This means the drug may not contain the correct amount of active ingredient in every dose, which could lead to ineffective treatment of infections. Consumers who have this prescription antibiotic should check their 230 mL bottles for the specific lot numbers S700065 or 700619. You should contact your doctor or pharmacist immediately to discuss an alternative treatment or replacement medication.
The drug failed to meet potency and uniformity standards, meaning a patient may receive less than the intended dose of the antibiotic. This can result in the failure to treat an underlying bacterial infection, potentially allowing the infection to worsen or become more difficult to treat.
Healthcare consultation and pharmacy refund.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.